Fitness of drug resistant HIV-1: methodology and clinical implications
- 13 December 2002
- journal article
- review article
- Published by Elsevier in Drug Resistance Updates
- Vol. 5 (6) , 224-233
- https://doi.org/10.1016/s1368-7646(02)00123-1
Abstract
No abstract availableKeywords
This publication has 60 references indexed in Scilit:
- Reduced Levels of CD4 Cell Spontaneous Apoptosis in Human Immunodeficiency Virus–Infected Patients with Discordant Response to Protease InhibitorsThe Journal of Infectious Diseases, 2002
- Viral Evolution in Response to the Broad-Based Retroviral Protease Inhibitor TL-3Journal of Virology, 2001
- A Novel Recombinant Marker Virus Assay for Comparing the Relative Fitness of HIV-1 Reverse Transcriptase VariantsJAIDS Journal of Acquired Immune Deficiency Syndromes, 2001
- Amino Acid Deletion at Codon 67 and Thr-to-Gly Change at Codon 69 of Human Immunodeficiency Virus Type 1 Reverse Transcriptase Confer Novel Drug Resistance ProfilesJournal of Virology, 2001
- Individual Contributions of Mutant Protease and Reverse Transcriptase to Viral Infectivity, Replication, and Protein Maturation of Antiretroviral Drug-Resistant Human Immunodeficiency Virus Type 1Journal of Virology, 2001
- HIV Type 1 Protease Cleavage Site Mutations and Viral Fitness: Implications for Drug Susceptibility Phenotyping AssaysAIDS Research and Human Retroviruses, 2000
- Substantial Correlation between HIV Type 1 Drug-Associated Resistance Mutations in Plasma and Peripheral Blood Mononuclear Cells in Treatment-Experienced PatientsAIDS Research and Human Retroviruses, 2000
- HIV-1 evolution under pressure of protease inhibitors: Climbing the stairs of viral fitnessJournal of Biomedical Science, 1999
- Proposed alternatives for the use of anti-HIV drugsDrug Resistance Updates, 1999
- Kinetic Characterization of Human Immunodeficiency Virus Type-1 Protease-resistant VariantsJournal of Biological Chemistry, 1996